Android app on Google Play

Credit Suisse Assumes Durata Therapeutics (DRTX) at Outperform

March 15, 2013 7:47 AM EDT Send to a Friend
Get Alerts DRTX Hot Sheet
Price: $14.16 +1.72%

Rating Summary:
    9 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 11 | New: 43
Trade DRTX Now!
Join SI Premium – FREE
Credit Suisse Assumes coverage on Durata Therapeutics (NASDAQ: DRTX) with a Outperform. PT $15.00.

For an analyst ratings summary and ratings history on Durata Therapeutics click here. For more ratings news on Durata Therapeutics click here.

Shares of Durata Therapeutics closed at $8.25 yesterday.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Credit Suisse

Add Your Comment